Oneness Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	24,727	26,600	41,683	88,028	95,221	109,494
Market Cap Growth	-10.20%	-36.18%	-52.65%	-7.55%	-13.04%	21.98%
Enterprise Value	19,420	21,578	35,382	80,760	87,283	102,525
Last Close Price	51.60	55.60	87.30	185.24	205.42	240.56
PE Ratio	-	-	-	-	264.52	-
PS Ratio	191.50	206.01	353.46	1014.35	89.36	1664.92
PB Ratio	2.36	2.54	3.26	6.07	6.40	7.77
P/TBV Ratio	2.65	2.85	3.75	7.17	7.61	9.49
EV/Sales Ratio	150.40	167.12	300.04	930.60	81.91	1558.95
EV/EBITDA Ratio	-	-	-	-	377.48	-
Debt / Equity Ratio	0.04	0.04	0.03	0.03	0.02	0.02
Debt / EBITDA Ratio	-	-	-	-	1.05	-
Net Debt / Equity Ratio	-0.52	-0.52	-0.52	-0.51	-0.52	-0.53
Net Debt / EBITDA Ratio	10.56	10.56	9.71	10.89	-33.66	10.56
Net Debt / FCF Ratio	11.31	11.31	16.73	14.33	8.04	19.58
Asset Turnover	0.01	0.01	0.01	0.01	0.07	0.00
Inventory Turnover	0.80	0.80	0.46	0.46	2.30	0.32
Quick Ratio	11.44	11.44	38.90	36.45	38.73	50.46
Current Ratio	11.81	11.81	39.87	37.23	39.47	51.21
Return on Equity (ROE)	-9.10%	-9.10%	-8.45%	-9.00%	2.43%	-2.96%
Return on Assets (ROA)	-3.95%	-3.95%	-4.68%	-4.43%	-0.96%	-3.53%
Return on Invested Capital (ROIC)	-15.31%	-14.32%	-16.28%	-15.39%	-2.75%	-14.26%
Return on Capital Employed (ROCE)	-7.20%	-7.20%	-8.10%	-7.20%	-1.60%	-5.60%
Earnings Yield	-4.23%	-3.93%	-2.79%	-1.49%	0.38%	-0.37%
FCF Yield	-1.95%	-1.81%	-0.95%	-0.58%	-1.02%	-0.35%
Dividend Yield	-	-	-	-	0.04%	-
Buyback Yield / Dilution	-0.25%	-0.25%	-0.97%	-0.40%	-3.58%	-6.82%
Total Shareholder Return	-0.25%	-0.25%	-0.97%	-0.40%	-3.54%	-6.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.